Revvity ignites scientific breakthroughs at SLAS2025

Revvity, Inc. is set to unveil its groundbreaking new Phenologic.AI™ software at SLAS2025 in San Diego, January 27-29. Designed to redefine cellular imaging workflows for Revvity’s Harmony™ and Signals Image Artist™ software packages, the Phenologic.AI software leverages pre-trained deep-learning models to analyze brightfield images, providing an additional multiplexing channel and streamlined workflows for live cell analysis.

FDA approves Artiva’s AlloNK and rituximab combo IND for SLE

AlloNK plus rituximab is intended to treat systemic lupus erythematosus in patients with active lupus nephritis. Credit: mi_viri / Shutterstock.com. The US Food and Drug

August 17, 2023

Cue Biopharma prioritizes autoimmune pipeline, axes a quarter of staff to save cash

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 27, 2024

Novo Nordisk acquires Alkermes’s Irish plant to expand manufacturing capacity

Share this article Novo Nordisk has been working to expand its manufacturing capabilities to keep up with the growing demand for its drugs. Image Credit:

December 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.